此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary Care

2018年10月11日 更新者:University of Zurich

Improving Access to Evidence-based Treatment for Depression: Effectiveness and Cost-effectiveness of Telephone-delivered Cognitive Behavioral Therapy (CBT) in Primary Care

The aim of the study is the examination of effectiveness and cost-effectiveness of a telephone-based psychotherapy (Tel-PT) for depression compared to treatment as usual in primary care.

研究概览

详细说明

The overall purpose of the study is to examine the effectiveness of telephone psychotherapy (Tel-PT) for the treatment of mild to moderate depression on different outcome-levels and under clinically representative conditions in Swiss primary health care. The randomized-controlled trial (RCT) will evaluate the primary hypothesis that Tel-PT is more effective than routine primary care (i.e. treatment as usual, TAU), more specifically, that it leads to significant higher reduction in depression severity than TAU at follow-up.

The intervention group (IG) receives a manualized short-term cognitive behavioral treatment, which is the adapted German version of the program "Creating a balance" developed in the USA. The therapy consists of one face-to-face and 8-12 telephone contacts and is carried out by a licensed psychotherapist.

More concrete, recruitment and inclusion of the patients will be carried out by the participating general practitioners (GPs). GPs will be instructed to screen patients at risk for depression, especially those revealing diffuse somatic symptoms and suffering from chronic diseases. If positively screened, patient's depressive symptoms are assessed with Patient Health Questionnaire (PHQ-9) and diagnosed according to ICD-10.

All GPs will receive an initial training prior to their participation, providing them with study information and procedures as well as training in screening procedure, psychodiagnostics and study enrolment.

Eligible patients are provided with detailed study information and asked to participate. Subsequently, patients will give informed consent. Patients will then be included into the study and fill out the baseline questionnaires (t0). After that, randomization will be carried out at the University of Zurich, based on an appropriately created computer algorithm. Both GPs and patients are informed about the results by the study team within two days. Subsequently, patients in control group (CG) will receive regular text messages and patients in the intervention group (IG) will be called by the study therapist to schedule an initial appointment.

In case of positive results, the overarching objective is the optimization of mental health services for depressed patients by implementing an evidence-based, accessible and cost-effective treatment option into primary care.

研究类型

介入性

注册 (实际的)

56

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Zurich、瑞士、8050
        • University of Zurich

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • PHQ-9 score of > 5 and ≤15.
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Minimum age of 18 years
  • Diagnosis of mild to moderate depression according to ICD-10 (F32.0, F32.1, F33.0, F33.1)

Exclusion Criteria:

  • Patients currently being in psychotherapeutic treatment or treatment in past three months
  • Suicidal tendencies or suicidality
  • Insufficient knowledge of German language
  • Health condition that does not allow questionnaire completion

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Tel-PT
Tel-PT receives a manualized short-term CBT. Treatment consists of one initial face-to-face appointment and 8-12 subsequent telephone sessions between patient and licensed therapist. Each telephone contact lasts between 20 and 30 minutes and take place on a weekly and later biweekly basis.
有源比较器:TAU and text messages
Control Group receives treatment as usual and additionally weekly text messages containing general information about depression.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in depressive symptoms
大体时间:t0 (baseline) and t2 (12 months after baseline)
The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
t0 (baseline) and t2 (12 months after baseline)

次要结果测量

结果测量
措施说明
大体时间
Change in depressive symptoms
大体时间:t0 (baseline) and t1 (four months after baseline)
The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
t0 (baseline) and t1 (four months after baseline)
Response
大体时间:t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Response defined as 50% reduction in the PHQ-9.
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Change in health-related quality of life
大体时间:t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Change in health-related quality of life is measured with the 12-Item Short Form Health Survey (SF-12; Bullinger & Kirchberger, 1998).
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Self-efficacy for management and relapse prevention in depression
大体时间:t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Depression self-efficacy scale for management and relapse prevention (Bush et al., 2001).
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Cost-effectiveness
大体时间:t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Health care utilization and productivity loss will be measured with an adapted version of the Client Sociodemographic and Service Receipt Inventory (CSSRI; Chisholm et al., 2000). For Switzerland, country-specific unit costs will be employed to calculate direct and indirect costs.
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Cost-effectiveness
大体时间:t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
Health-related quality of life for the economic analyses will be measured using the EQ-5D-5L (The EuroQuol Group, 1990), Quality-adjusted life years (QALYs) based on the EQ-5D index will be determined and the incremental cost-effectiveness ratio (ICER) will be computed.
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)

其他结果措施

结果测量
措施说明
大体时间
Acceptance and satisfaction with the intervention
大体时间:t1 (four months after baseline)
Patients' and therapists' acceptance and satisfaction with the intervention will be assessed by a self-constructed questionnaire.
t1 (four months after baseline)
Process and structural variable
大体时间:t1 (four months after baseline), t2 (12 months after baseline)
Mean duration of telephone contacts
t1 (four months after baseline), t2 (12 months after baseline)
Process and structural variable
大体时间:t1 (four months after baseline), t2 (12 months after baseline)
Mean number of telephone contacts.
t1 (four months after baseline), t2 (12 months after baseline)
Process and structural variable
大体时间:t1 (four months after baseline), t2 (12 months after baseline)
Dropout rate
t1 (four months after baseline), t2 (12 months after baseline)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Birgit Watzke, Prof、University of Zurich, Department of Clinical Psychology and Psychotherapy Research

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2016年1月1日

初级完成 (预期的)

2019年3月1日

研究完成 (预期的)

2019年3月1日

研究注册日期

首次提交

2015年12月3日

首先提交符合 QC 标准的

2016年1月27日

首次发布 (估计)

2016年1月28日

研究记录更新

最后更新发布 (实际的)

2018年10月16日

上次提交的符合 QC 标准的更新

2018年10月11日

最后验证

2018年10月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • BW-0417

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Tel-PT的临床试验

3
订阅